Retraction notices

The role of second generation sequencing technology and nanomedicine in the monitoring and treatment of lower extremity deep vein thrombosis susceptibility genes

Type

Reinstatement

Notice date

1/29/2024 0:00

Journal

Bioengineered

Publisher

Taylor and Francis

Notice DOI

10.1080/21655979.2024.2302653

Original paper DOI

10.1080/21655979.2021.2003926

Reasons

• Concerns/Issues about Data
• Concerns/Issues about Human Subject Welfare
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Bioengineered